Zafirlukast

Links shared publicly online about this topic

FDA Alert: Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)

drugs.com — “FDA Alert: Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on June 13, 2009 at 1:40 am By:

drugscom Drugs.com Health Site

FDA Alert - Leukotriene Inhibitors for Asthma Get 'Precaution' Labeling for Possible Neuropsychiatric Events - http://bit.ly/9q3LW

3 years ago...

FDA Alert: Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)

drugs.com — “FDA Alert: Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 29, 2009 at 7:07 pm By:

drugscom Drugs.com Health Site

FDA Alert - Update on Leukotriene Inhibitors: Precaution Labeling for Possible Neuropsychiatric Events - http://bit.ly/SjR6o

2 years ago...

Asthma Drugs Get 'Precaution' Labeling for Possible Psychiatric Side Effects - m

myoptumhealth.com — “Read the news article Asthma Drugs Get 'Precaution' Labeling for Possible Psychiatric Side Effects at www.myOptumHealth.comView full resource at myoptumhealth.com

  • View Related
  • Share

Most Recently Shared on June 13, 2009 at 2:22 am By:

myOptumHealth myOptumHealth.com Health Site

Asthma Drugs Get 'Precaution' Labeling for Possible Psychiatric Side Effects: FDA says users of Singulair and si.. http://tinyurl.com/lhm679

3 years ago...

New York City NYC Allergy Doctor News & Blog | Dr Lubitz

nycallergydoctor.com — “Dr. Lubitz is a highly trained, well known, accredited Allergist who has been specializing in allergy and immunology for the last 20 years in the Manhattan area. He has four convenient locations in New York City. He regularly sees several nasal allergy, asthma and hive patients but can treat all of you allergy and immunology needs.View full resource at nycallergydoctor.com

  • View Related
  • Share

Most Recently Shared on June 8, 2010 at 3:14 pm By:

NYCAllergyDr Dr. Arthur Lubitz Active Health Library, Doctor, Internist, Allergist, and Physician

Read how some athletes learned to manage seasonal allergies or asthma that made performance difficult http://bit.ly/aFEI7C

2 years ago...

New Precautions on Asthma Meds « Blisstree

blisstree.com — “The FDA has requested that a new precaution be added to the drug prescribing information for some popular asthma medications. The medicines are known as leukotriene modifiers and include Singulair (montelukast) Accolate (zafirlukast) ZyfView full resource at blisstree.com

  • View Related
  • Share

Most Recently Shared on June 15, 2009 at 7:50 am By:

healthy_tweets health news Health News

RT @VirginiaWright New Precautions on Asthma Meds : Blisstree - Family, Health, Home ... http://bit.ly/N835O

3 years ago...

Dr Reddy's gets FDA nod to launch anti-asthma tablets in US - The Economic Times

economictimes.indiatimes.com — “Drug firm Dr Reddy's Laboratories today said it has received approval from US health regulator to launch generic Zafirlukast tablets, used for treating asthma, in the American market.View full resource at economictimes.indiatimes.com

  • View Related
  • Share

Most Recently Shared on November 20, 2010 at 2:03 pm By:

wheezemd Michael Blaiss, MD Physician, Doctor, and Allergist

Dr Reddy's gets FDA nod to launch anti-asthma tablets in US - The Economic Times: http://is.gd/htKCU

1 year ago...

Leukotriene modifier drug label change requested by FDA - MPR

empr.com — “The FDA has requested that manufacturers of leukotriene modifiers include a precaution in the drug labeling regarding neuropsychiatric events that have been reported in some patients taking montelukast (Singulair, from Merck), zafirlukast (Accolate, from AstraZeneca) and zileuton (Zyflo CR from Cornerstone Therapeutics).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on June 16, 2009 at 6:39 pm By:

eMPR MPR Medical Publisher

MPR News: Leukotriene modifier drug label change requested by FDA: The FDA has requested that manufactu.. http://tinyurl.com/nbs7rz

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • drugscom

    Drugs.com

    Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.

    View Profile

  • drugscom

    Drugs.com

    Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.

    View Profile

  • myOptumHealth

    myOptumHealth.com

    Focused on online health and wellness, diseases and conditions, medical tests and procedures, helping people live their lives to the fullest.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390